scholarly journals Enrichment of CD34 positive cells in human umbilical cord blood and in vitro expansion of hematopoietic progenitor cells.

1994 ◽  
Vol 40 (5) ◽  
pp. 694-701
Author(s):  
Emi Kadowaki ◽  
Tsuneo A. Takahashi ◽  
Yuko Mogi ◽  
Akira Sohma ◽  
Yutaka Yorozu ◽  
...  
1993 ◽  
Vol 2 (2) ◽  
pp. 243-245 ◽  
Author(s):  
ARNON NAGLER ◽  
MARGO PEACOCK ◽  
MARISA TANTOCO ◽  
DONALD LAMONS ◽  
THOMAS B. OKARMA ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Guadalupe R. Fajardo-Orduña ◽  
Héctor Mayani ◽  
Patricia Flores-Guzmán ◽  
Eugenia Flores-Figueroa ◽  
Erika Hernández-Estévez ◽  
...  

Mesenchymal stem/stromal cells (MSCs) from bone marrow (BM) have been used in coculture systems as a feeder layer for promoting the expansion of hematopoietic progenitor cells (HPCs) for hematopoietic cell transplantation. Because BM has some drawbacks, umbilical cord blood (UCB) and placenta (PL) have been proposed as possible alternative sources of MSCs. However, MSCs from UCB and PL sources have not been compared to determine which of these cell populations has the best capacity of promoting hematopoietic expansion. In this study, MSCs from UCB and PL were cultured under the same conditions to compare their capacities to support the expansion of HPCs in vitro. MSCs were cocultured with CD34+CD38−Lin− HPCs in the presence or absence of early acting cytokines. HPC expansion was analyzed through quantification of colony-forming cells (CFCs), long-term culture-initiating cells (LTC-ICs), and CD34+CD38−Lin− cells. MSCs from UCB and PL have similar capacities to increase HPC expansion, and this capacity is similar to that presented by BM-MSCs. Here, we are the first to determine that MSCs from UCB and PL have similar capacities to promote HPC expansion; however, PL is a better alternative source because MSCs can be obtained from a higher proportion of samples.


Sign in / Sign up

Export Citation Format

Share Document